Cases & Deals

Sanofi defends proposed class action alleging improper Orange Book listings and sham patent litigation

Clients Sanofi-Aventis U.S. LLC

Jones Day is defending Sanofi-Aventis U.S. LLC against a proposed class action alleging that Sanofi improperly listed certain patents in the FDA's Orange Book and engaged in sham patent litigation to forestall competition for its diabetes drug, Lantus.

In re Lantus Direct Purchaser Antitrust Litigation, No. 16-cv-12652 (D. Mass.); No. 18-02086 (1st Cir.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.